• Home
  • MF Research
  • ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

ITI Pharma and Healthcare Fund - Regular Plan - Growth Option

arrow-down
NAV
₹ 15.9884 ₹ -0.01 (-0.09 %)
as on 16-05-2025
Asset Size (AUM)
219 Cr
Launch Date
Nov 08, 2021
Investment Objective
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.
Minimum Investment 5000.0
Minimum Top-up 1000.0
Investment Returns Since Launch in Nov 08, 2021
arrow-up

14.26

%
3 M
6 M
1 Y
3 Y
10 Y
Inception
Sharp Ratio
0.77 %
Expense Ratio
2.35%
Volatility
14.52 %
Fund House
ITI Mutual Fund
Fund Manager
Dhimant Shah, Rohan Korde, Rajesh Bhatia
Key Features
Scheme description
Minimum Purchase Application Amount
Rs. 5000.0 (plus in multiples of Rs. 1000.0)

Entry Load
Not applicable
Exit Load
Exit load of 1% if redeemed within 12 months.
Indicative Investment Horizon
5 Years and above
Asset Allocation
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4AssetsCash & Cash EquivalentsEquity
Fund Performance
Fund's historical return comparison with other asset classes
Created with Highcharts 4.1.4FundFDGoldNifty
Fund₹ 11786
FD₹ 10600
Gold₹ 10800
Nifty₹ 11756
Performance

Scheme Performance (%)

Data as on - 16-05-2025
Created with Highcharts 4.1.4ReturnsITI Pharma and Healthcare Fund - Regular Plan - Growth OptionNIFTY Healthcare TRIEquity: Sectoral-Pharma and HealthcareYTD1 Month3 Month6 Month1 Year3 Years5 Years10 YearsSince Launch-100102030

Yearly Performance (%)

Created with Highcharts 4.1.4ValuesITI Pharma and Healthcare Fund - Regular Plan - Growth OptionNIFTY Healthcare TRIEquity: Sectoral-Pharma and Healthcare2016201720182019202020212022202320242025-20020406080
Investment Returns Calculator
Amount InvestedFund ValueProfitReturns
Fund120,000121,4931,4932.72
Benchmark120,000122,6992,6994.94
Rolling returns are the annualized returns of the scheme taken for a specified period (rolling returns period) on every day/week/month and taken till the last day of the duration. In this chart we are showing the annualized returns over the rolling returns period on every day from the start date and comparing it with the benchmark. Rolling returns is the best measure of a fund's performance. Trailing returns have a recency bias and point to point returns are specific to the period in consideration. Rolling returns, on the other hand, measures the fund's absolute and relative performance across all timescales, without bias.
Peer Comparison
Scheme Name Inception Date 1 Year Return % 2 Year Return % 3 Year Return % 5 Year Return % 10 Year Return %
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option 08-11-2021 17.85 30.91 21.85 0.0 0.0
HDFC Pharma and Healthcare Fund - Growth Option 04-10-2023 26.65 0.0 0.0 0.0 0.0
WhiteOak Capital Pharma and Healthcare Fund Regular Plan Growth 06-02-2024 25.95 0.0 0.0 0.0 0.0
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund - Cumulative Option 25-07-2018 23.26 38.75 27.9 25.98 0.0
UTI Healthcare Fund - Regular Plan - Growth Option 05-08-2005 20.85 34.77 23.63 22.48 11.2
Portfolio Analysis
Portfolio as on 30-04-2025
Sector Allocation
SectorAllocation (%)
Healthcare93.28
Chemicals4.22
N/A2.5
Portfolio Holdings
CompanyHoldings (%)
SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-16.72
DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-6.23
LUPIN LIMITED EQ NEW F.V. RS.2/-5.83
MAX HEALTHCARE INSTITUTE LIMITED EQ5.34
APOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-5.3100000000000005
SUVEN PHARMACEUTICALS LIMITED EQ5.2
AUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-4.24
TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-4.130000000000001
MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-3.06
ALKEM LABORATORIES LIMITED EQ2.91
ASTER DM HEALTHCARE LIMITED EQ2.87
TREPS 02-May-20252.68
FORTIS HEALTHCARE LIMITED. EQ2.37
ABBOTT INDIA LIMITED EQ2.31
NEULAND LABORATORIES LIMITED EQ1.97
GRANULES INDIA LIMITED EQ NEW FV RE. 1/-1.82
WOCKHARDT LIMITED EQ FV RS. 5/-1.68
HEALTHCARE GLOBAL ENTERPRISES LTD EQ1.6199999999999999
FDC LIMITED EQ FV RE 1/-1.5
SUMITOMO CHEMICAL INDIA LIMITED EQ1.35
SUPRIYA LIFESCIENCE LIMITED EQ1.3299999999999998
ORCHID PHARMA LIMITED EQ NEW FV RS. 10/-1.3299999999999998
RAINBOW CHILDRENS MEDICARE LIMITED EQ1.27
JB Chemicals & Pharmaceuticals Limited1.1900000000000002
Dr. Reddys Laboratories Ltd1.17
EMCURE PHARMACEUTICALS LIMITED EQ1.09
CIPLA LIMITED EQ NEW FV RS.2/-1.09
GLAXOSMITHKLINE PHARMACEUTICALS LTD EQ1.0699999999999998
GLAND PHARMA LIMITED EQ NEW FV Re.1/-1.05
CAPLIN POINT LABORATORIES LIMITED EQ NEW FV RS. 2/-1.04
VIJAYA DIAGNOSTIC CENTRE LIMITED EQ NEW FV Re.1/-1.02
SRF LIMITED EQ0.98
SEQUENT SCIENTIFIC LIMITED EQ NEW FV RS. 2/-0.98
UPL LIMITED EQ NEW FV RS.2/-0.98
SHILPA MEDICARE LIMITED EQ NEW FV RE. 1/-0.97
LAURUS LABS LIMITED EQ NEW FV RS. 2/-0.97
STELIS BIOPHARMA LIMITED EQ NEW FV RE.1/-0.9299999999999999
LINDE INDIA LIMITED EQ0.91
Sai Life Sciences Limited0.8500000000000001
STRIDES PHARMA SCIENCE LIMITED EQ0.8200000000000001
Net Receivables / (Payables)-0.18
Sector Allocation
Created with Highcharts 4.1.4HealthcareOthers
Portfolio Holdings
Created with Highcharts 4.1.4SUN PHARMACEUTICAL INDUSTRIES LTD. EQ NEW F.V. RE.1/-DIVIS LABORATORIES LIMITED EQ NEW RS. 2/-LUPIN LIMITED EQ NEW F.V. RS.2/-MAX HEALTHCARE INSTITUTE LIMITED EQAPOLLO HOSPITALS ENTERPRISE LIMITED EQ NEW F.V. RS.5/-SUVEN PHARMACEUTICALS LIMITED EQAUROBINDO PHARMA LIMITED EQ NEW F.V. RE.1/-TORRENT PHARMACEUTICALS LIMITED EQ NEW FV RS.5/-MANKIND PHARMA LIMITED EQ NEW FV RE. 1/-Others